Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis

por Cheng, Shih-Lung
Publicado 2018

Immunologic Pathophysiology and Airway Remodeling Mechanism in Severe Asthma: Focused on IgE-Mediated Pathways

por Cheng, Shih-Lung
Publicado 2021

Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment

por Cheng, Shih-Lung
Publicado 2021

Molecular Targets for Biological Therapies of Severe Asthma: Focus on Benralizumab and Tezepelumab

por Cheng, Shih-Lung
Publicado 2021

Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System

por Gomes, Felisbela, Cheng, Shih-Lung
Publicado 2023

A review of omalizumab for the management of severe asthma

por Lin, Ching-Hsiung, Cheng, Shih-Lung
Publicado 2016

Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts

por Cheng, Shih-Lung, Lin, Ching-Hsiung
Publicado 2016

COPD Guidelines in the Asia-Pacific Regions: Similarities and Differences

por Cheng, Shih-Lung, Lin, Ching-Hsiung
Publicado 2021

From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease

por Wang, Hsu-Hui, Cheng, Shih-Lung
Publicado 2021

Application of High-Flow Nasal Cannula in COVID-19: A Narrative Review

por Liu, Cheng-Wei, Cheng, Shih-Lung
Publicado 2022

Reply to Crimi, C.; Cortegiani, A. Comment on “Liu et al. Application of High-Flow Nasal Cannula in COVID-19: A Narrative Review. Life 2022, 12, 1419”

por Liu, Cheng-Wei, Cheng, Shih-Lung
Publicado 2022

Early achievement and maintenance of stable asthma control using initially higher-dose inhaled corticosteroids as part of combination therapy: an open-label pilot study

por Cheng, Shih-Lung, Wang, Hao-Chien, Kuo, Sow-Hsong
Publicado 2013

Mesenchymal Stem Cell Administration in Patients with Chronic Obstructive Pulmonary Disease: State of the Science

por Cheng, Shih-Lung, Lin, Ching-Hsiung, Yao, Chao-Ling
Publicado 2017

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD

por Cheng, Shih-Lung, Wang, Hsu Hui, Lin, Ching-Hsiung
Publicado 2017

Asthma and COVID-19 Associations: Focus on IgE-Related Immune Pathology

por Wang, Chung-Jen, Cheng, Shih-Lung, Kuo, Sow-Hsong
Publicado 2022

Elevated placenta growth factor predicts pneumonia in patients with chronic obstructive pulmonary disease under inhaled corticosteroids therapy

por Cheng, Shih-Lung, Wang, Hao-Chien, Cheng, Shih-Jung, Yu, Chong-Jen
Publicado 2011

Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pn...

por Cheng, Shih-Lung, Su, Kang-Cheng, Wang, Hao-Chien, Perng, Diahn-Warng, Yang, Pan-Chyr
Publicado 2014

Current Progress of COPD Early Detection: Key Points and Novel Strategies

por Lin, Ching-Hsiung, Cheng, Shih-Lung, Chen, Chiung-Zuei, Chen, Chia-Hung, Lin, Sheng-Hao, Wang, Hao-Chien
Publicado 2023

The Trend of TIM3 Expression on T Cells in Patients With Nontuberculous Mycobacterial Lung Disease: From Immune Cell Dysfunction to Clinical Severity

por Wang, Ping-Huai, Wu, Ming-Fang, Hsu, Chi-Yu, Pan, Sheng-Wei, Shu, Chin-Chung, Cheng, Shih-Lung
Publicado 2021

The Benefits of Molnupiravir Treatment in Healthcare Facilities Patients with COVID-19

por Cheng, Shih-Lung, Wang, Ping-Huai, Chang, Cheng-Yu, Wang, Hsu-Hui, Wang, Chung-Jen, Chiu, Kuan-Ming
Publicado 2023